Zhe Gong

Zhe Gong

Auto-generated profile, based on publicly available information

Zhe Gong

Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2018 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
ZGZhe Gong
Zhe Gong
JPJingrui Pan
Jingrui Pan
QSQingyu Shen
Qingyu Shen
MLMei Li
Mei Li
YPYing Peng
Ying Peng
Nod-like receptor protein 3 (NLRP3) inflammasome is a crucial factor in mediating inflammatory responses after cerebral ischemia/reperfusion (I/R), but the cellular location of NLRP3 inflammasome in cerebral I/R has yet come to a conclusion, and there is still no specific evidence to state the relationship between mitochondria and the NLRP3 inflammasome in cerebral I/R. In the present study, we detected the cellular localization of NLRP3 inflammasomes in a transient middle cerebral artery occlusion (tMCAO) rat model and a transwell co-culture cell system under oxygen-glucose deprivation/reoxygenation (OGD/R) conditions. Then, we investigated the relationship between mitochondrial dysfunction and the activation of NLRP3 inflammasomes in different cell types after OGD/R and cerebral I/R injury. Our results showed that NLRP3 inflammasomes were first activated in microglia soon after cerebral I/R injury onset and then were expressed in neurons and microvascular endothelial cells later, but they were mainly in neurons. Furthermore, mitochondrial dysfunction played an important role in activating NLRP3 inflammasomes in microglia after OGD/R, and mitochondrial protector could inhibit the activation of NLRP3 inflammasomes in cerebral I/R rats. Our findings may provide novel insights into the cell type-dependent activation of NLRP3 inflammasomes at different stages of cerebral I/R injury and the role of mitochondrial dysfunction in activating the NLRP3 inflammasome pathway.

30 April 2024 in Neurotherapeutics
Verified
Journal Article
Open access
QLQingsheng Li
Qingsheng Li
LYLingfei Yang
Lingfei Yang
KWKaixin Wang
Kaixin Wang
ZCZiyi Chen
Ziyi Chen
HLHuimin Liu
Huimin Liu
YJYanjie Jia
Yanjie Jia
In the context of stroke and revascularization therapy, brain ischemia-reperfusion injury is a significant challenge that leads to oxidative stress and inflammation. Central to the cell's intrinsic immunity is the cGAS-STING pathway, which is typically activated by unusual DNA structures. The involvement of oxidized mitochondrial DNA (ox-mtDNA)-an oxidative stress byproduct-in this type of neurological damage has not been fully explored. This study is among the first to examine the effect of ox-mtDNA on the innate immunity of neurons following ischemia-reperfusion injury. Using a rat model of transient middle cerebral artery occlusion and a cellular model of oxygen-glucose deprivation/reoxygenation, we have discovered that ox-mtDNA activates the cGAS-STING pathway in neurons. Importantly, pharmacologically limiting the release of ox-mtDNA into the cytoplasm reduces inflammation and improves neurological functions. Our findings suggest that targeting ox-mtDNA release may be a valuable strategy to attenuate brain ischemia-reperfusion injury following revascularization therapy for acute ischemic stroke.

21 June 2024 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
HLHuiMin Liu
HuiMin Liu
QZQiang Zhang
Qiang Zhang
QHQianMeng Hao
QianMeng Hao
QLQingSheng Li
QingSheng Li
LYLingFei Yang
LingFei Yang
YJYanjie Jia
Yanjie Jia
Background: Emerging evidence suggests that alterations in BCAA metabolism may contribute to the pathogenesis of sarcopenia. However, the relationship between branched-chain amino acids (BCAAs) and sarcopenia is incompletely understood, and existing literature presents conflicting results. In this study, we conducted a community-based study involving > 100,000 United Kingdom adults to comprehensively explore the association between BCAAs and sarcopenia, and assess the potential role of muscle mass in mediating the relationship between BCAAs and muscle strength. Methods: Multivariable linear regression analysis examined the relationship between circulating BCAAs and muscle mass/strength. Logistic regression analysis assessed the impact of circulating BCAAs and quartiles of BCAAs on sarcopenia risk. Subgroup analyses explored the variations in associations across age, and gender. Mediation analysis investigated the potential mediating effect of muscle mass on the BCAA-muscle strength relationship. Results: Among 108,017 participants (mean age: 56.40 ± 8.09 years; 46.23% men), positive associations were observed between total BCAA, isoleucine, leucine, valine, and muscle mass (beta, 0.56–2.53; p < 0.05) and between total BCAA, leucine, valine, and muscle strength (beta, 0.91–3.44; p < 0.05). Logistic regression analysis revealed that increased circulating valine was associated with a 47% reduced sarcopenia risk (odds ratio = 0.53; 95% confidence interval = 0.3–0.94; p = 0.029). Subgroup analyses demonstrated strong associations between circulating BCAAs and muscle mass/strength in men and individuals aged ≥ 60 years. Mediation analysis suggested that muscle mass completely mediated the relationship between total BCAA, and valine levels and muscle strength, partially mediated the relationship between leucine levels and muscle strength, obscuring the true effect of isoleucine on muscle strength. Conclusion: This study suggested the potential benefits of BCAAs in preserving muscle mass/strength and highlighted muscle mass might be mediator of BCAA-muscle strength association. Our findings contribute new evidence for the clinical prevention and treatment of sarcopenia and related conditions involving muscle mass/strength loss.

23 February 2024 in Brain Research
Verified
Journal Article
Open access
LYLingfei Yang
Lingfei Yang
QLQingsheng Li
Qingsheng Li
KWKaixin Wang
Kaixin Wang
HLHuimin Liu
Huimin Liu
XYXuan Yang
Xuan Yang
YJYanjie Jia
Yanjie Jia
Reduced blood supply to the brain activates the intracranial inflammatory response, a key contributor to secondary brain damage in ischemic stroke. Post-stroke, activation of peripheral immune cells leads to systemic inflammatory responses. Usingin vivo approaches, we investigated meningeal lymphatics' role in central immune cell infiltration and peripheral immune cell activation. The bilateral deep cervical lymph nodes (dCLNs) were removed 7 days before right middle cerebral artery occlusion in Sprague Dawley (SD) rats. At 3, 24, and 72 h post-intervention, brain immune cell infiltration and microglial and astrocyte activation were measured, while immune cells were classified in the spleen and blood. Inflammatory factor levels in peripheral blood were analyzed. Simultaneously, reverse verification was conducted by injecting AAV-vascular endothelial growth factor C (AAV-VEGFC) adenovirus into the lateral ventricle 14 days before middle cerebral artery occlusion (MCAO) induction to enhance meningeal lymph function. Blocking meningeal LVs in MCAO rats significantly reduced infarct area and infiltration, and inhibited microglia and pro-inflammatory astrocytes activation. After removing dCLNs, CD4+ T lymphocytes, CD8+ T lymphocytes, B lymphocytes, macrophages, and neutrophils in the spleen and blood of MCAO rats decreased significantly at different time points. The levels of inflammatory factors IL-6, IL-10, IL-1β, and TNF-α in plasma decreased significantly. Tests confirmed the results, and AAV-VEGFC-induced MCAO rats provided reverse validation.

1 July 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
KWKaixin Wang
Kaixin Wang
LYLingfei Yang
Lingfei Yang
QLQingsheng Li
Qingsheng Li
XYXuan Yang
Xuan Yang
ZCZiyi Chen
Ziyi Chen
ZGZhe Gong
Zhe Gong
Background: Ischemic stroke (IS) is one of the leading causes of death and disability in the world, and alcohol consumption has been gaining attention as an independent risk factor for IS. Blood-brain barrier (BBB) dysfunction and neuroinflammation are the core of cerebral ischemia/reperfusion (I/R) injury, and pericytes play a crucial role in the structure and function. This study is to explore the effects of long-term alcohol consumption on IS and the potential mechanisms of pericytes. Methods: Rat models of long-term alcohol intake followed by transient middle cerebral artery occlusion stroke (EtOH+tMCAO) and cell models of oxygen-glucose deprivation/reoxygenation (OGD/R) with alcohol pre-treatment were constructed. Results: Worsened infarct volume, neurological scores, and BBB disruption were observed in the EtOH+tMCAO group compared with the tMCAO group, and immunofluorescence staining showed increased pericytes NLPR3 inflammasome activation at the ischemic penumbra. In vitro, pericyte mortality and LDH release elevated pre-treated by alcohol after OGD/R, and amplified expression of NLRP3 inflammasome was detected by Western blotting and qPCR. Alcohol pre-treatment activated the TLR4/NF-κB pathway, and transfecting pericytes with TLR4-small interfering RNA (siRNA) to block TLR4 signaling markedly restrained NLRP3 inflammasome over-activation. Injecting TAK-242 in rats alleviated neurological impairment caused by alcohol. Conclusion: Long-term alcohol pre-treatment aggravated ischemic stroke-induced brain damage by activating NLRP3 inflammasome via TLR4/NF-κB signaling pathway in the pericytes.

1 January 2024 in Neuropharmacology and Therapy
Verified
Journal Article
Open access
PDF file
ZCZiyi Chen
Ziyi Chen
QLQingsheng Li
Qingsheng Li
KWKaixin Wang
Kaixin Wang
LYLingfei Yang
Lingfei Yang
YJYanjie Jia
Yanjie Jia
ZGZhe Gong
Zhe Gong
Inflammation is a key element in the pathophysiology of ischemic stroke. The current effective treatments for ischemic stroke are almost exclusively based on reperfusion of occluded vessels. An increasing number of studies are attempting to develop better treatment strategies for ischemic stroke by investigating the involvement of neuroinflammation in the pathogenesis. There is a growing focus on the inflammatory response of glial cells within the neurovascular unit (NVU) in ischemic stroke, while pericytes, despite their central position within the NVU and having interactions with all cellular components through direct contact or signaling pathways, have been less studied in terms of the related inflammatory mechanisms. Pericytes regulate blood flow, modulate the entry of peripheral immune cells into the brain parenchyma, and contribute to the integrity of the blood-brain barrier (BBB), which situates pericytes in a unique position to significantly influence NVU function. This article discusses the potential inflammatory mechanisms of pericytes in ischemic stroke from three perspectives: pericytes and innate immunity in the brain; pericytes and infiltration of peripheral inflammatory cells; and pericytes and BBB repair mechanisms. The goal is to better understand the role of pericytes in the pathogenesis of ischemic stroke and to provide new insight for research and treatment.